The New York Times > Business > F.D.A. Failing in Drug Safety, Official Asserts

The New York Times > Business > F.D.A. Failing in Drug Safety, Official Asserts

Merck & the Broken FDA

Accounts of the Senate Hearings concerning the inability of the FDA to Protect Us

The FDA is Broken

Where you can find all the latest breaking news concerning VIOXX

Congress Told FDA Failed Public on VioxxReuters - NY,USA... The US Food and Drug Administration failed the public in its oversight of Merck & Co Inc.'s (MRK.N: Quote, Profile, Research) withdrawn painkiller Vioxx and is ... See all stories on this topic

Merck faces first hearing on Vioxx as lawsuits mountUSA Today - McLean,VA,USA... Each man died after taking doctor-prescribed Vioxx, the pain medication manufactured by Merck (MRK). The deaths are also among at ...

Charfoos & Christensen: National Class Action Lawsuit Filed ...Yahoo News (press release) - USA... Both Harry Brooks and Gerald Norback were prescribed Vioxx for pain relief never suspecting that the prescription medication would cause them to suffer heart ...

Vioxx Victims to Meet With Experts at Conference Hosted by Netlaw ...PR Newswire (press release) - USA18 /PRNewswire/ -- A special Atlanta seminar, sponsored by Netlaw, will be held November 21st, to advise Vioxx users of their rights against the drug giant ...

FDA Defends Its Handling of Vioxx Safety7Online.com - New York,NY,USAWASHINGTON Nov 18, 2004 -- Amid questions about whether the arthritis drug Vioxx was taken off the market soon enough, a key senator suggested Friday that an ... See all stories on this topic
FDA defends its handling of Vioxx safety issuesWBOC TV 16 -
Salisbury,MD,USAWASHINGTON Just hours ahead of a hearing on Vioxx safety this morning, the Food and Drug Administration is defending its oversight. ...
FDA clarifies it's position on VioxxNews-Medical.net - World... weeks, various allegations and characterizations have circulated and been reported on regarding FDA's approval and post market review of the drug Vioxx, a "Cox ...

Sympathy for PfizerMotley Fool - USA... On September 30, Motley Fool Income Investor holding Merck (NYSE: MRK) announced it was pulling Vioxx off the shelves because a study suggested the drug ... See all stories on this topic

Study Suggests How COX Drugs Cause Heart DiseaseYahoo News - USA... The drugs, known as COX-2 inhibitors, include Merck and Co.'s Vioxx, which earned the company $2.55 billion a year but was pulled off the market on Sept. ... See all stories on this topic